PlainRecalls
FDA Drug Moderate Class II Ongoing

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Reported: July 30, 2025 Initiated: June 30, 2025 #D-0541-2025

Product Description

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Reason for Recall

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
13,680 ampoules
Distribution
Distributed Nationwide in the USA
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton). Recalled by Cipla USA, Inc.. Units affected: 13,680 ampoules.
Why was this product recalled?
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2025. Severity: Moderate. Recall number: D-0541-2025.